Accession Number: | 0001209191-20-010550 |
Date: | 2020-02-17 |
Issuer: | VERTEX PHARMACEUTICALS INC / MA (VRTX) |
Original Submission Date: |
SACHDEV AMIT
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON, MA 02210
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-02-17 | F | 3,262 | d | $241.50 | 42,936 | direct | ||
COMMON STOCK | 2020-02-18 | S | 720 | d | $242.04 | 42,216 | direct | ||
COMMON STOCK | 2020-02-18 | S | 1,260 | d | $242.85 | 40,956 | direct | ||
COMMON STOCK | 2020-02-18 | S | 540 | d | $244.08 | 40,416 | direct | ||
COMMON STOCK | 2020-02-18 | S | 720 | d | $245.15 | 39,696 | direct | ||
COMMON STOCK | 2020-02-18 | S | 249 | d | $245.82 | 39,447 | direct | ||
COMMON STOCK | 2020-02-17 | 0 | $0.00 | 16,190 | indirect | ||||
COMMON STOCK | 2020-02-17 | 0 | $0.00 | 882 | indirect |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | transaction made pursuant to mr. sachdev's company approved trading plan under rule 10b5-1. |
f2 | open market sales reported on this line occurred at a weighted average price of $242.04 (range $241.43 to $242.40). |
f3 | mr. sachdev undertakes to provide (upon request by the sec staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
f4 | open market sales reported on this line occurred at a weighted average price of $242.85 (range $242.45 to $243.32). |
f5 | open market sales reported on this line occurred at a weighted average price of $244.08 (range $243.52 to $244.43). |
f6 | open market sales reported on this line occurred at a weighted average price of $245.15 (range $244.77 to $245.51). |
f7 | open market sales reported on this line occurred at a weighted average price of $245.82 (range $245.82 to $245.85). |